Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Debbie A Lawlor Department of Social Medicine, University of
Bristol, Bristol BS8 2PR Correspondence to: D A Lawlor
D.A.Lawlor{at}bristol.ac.uk
The sex difference in mortality from coronary heart disease
decreases with increasing age, suggesting a protective effect of
oestrogen in premenopausal women. This decrease is, however, the result
of a deceleration in death rates in men, with no change in rates in
women around the age of menopause.1 The age specific rate
of breast cancer We obtained data on age specific mortality from coronary heart
disease (ICD-9 (international classification of diseases, 9th revision): 410-414) for women and men and from breast cancer (ICD-9: 174) for women in England and Wales from the Office for National Statistics and in Japan from the World Health Organization. We calculated five year aggregate rates for each country (1994-8 for
England and Wales and 1993-7 for Japan) and plotted them on a
semilogarithmic scale.
Coronary heart disease mortality in women from both countries increased
with age, and in both countries the death rate in men decelerated at
older ages, reducing the magnitude of the sex difference (figure). We
found no inflection in age specific mortality from coronary heart
disease in women around the age of menopause in either England and
Wales or Japan. In contrast, mortality from breast cancer began to
decelerate around the time of the menopause in both
groups.
Mortality from breast cancer in Japanese women is about half that
from coronary heart disease in women in England and Wales at ages
45-54; it is thus unlikely that the low mortality from coronary heart
disease makes detection of a menopause effect difficult. The inflection
in breast cancer mortality occurs over a narrow age range, suggesting
that if effects of menopausal oestrogen on coronary heart disease
occurred they too should operate over a similar range and be
observable. However, coronary heart disease is associated with several
environmental risk factors, and if the effect of oestrogen on risk of
coronary heart disease is small relative to other risk factors then any
effect of the menopause may be masked.
Witteman et al argue that age related trends in coronary heart disease
mortality are not inconsistent with an effect of the menopause.4 They used simulation models based on levels of risk of coronary heart disease in men to estimate age related trends in
"women who never experience a menopause."4 Such
analyses are unrealistic and unhelpful.
Work on the aetiology of coronary heart disease in women has been
dominated by the idea that oestrogen plays an important part and is
responsible for the sex difference at younger ages. The implications of
this are that higher rates of coronary heart disease in men are seen as
inevitable and that postmenopausal hormone replacement therapy has
become the mainstay of coronary heart disease prevention in women. We
conclude that environmental factors are the most important determinants
of coronary heart disease in women and men and of the difference in
coronary heart disease rates between women and men.5
a condition associated with endogenous
oestrogen
does show a change around the age of menopause among women
in the United States.2 The relatively low rates of
coronary heart disease in premenopausal women may make it difficult to
detect an effect of the menopause.3 Rates of breast cancer
among Japanese women are low. If low rates of coronary heart disease
around the time of the menopause explain the lack of an effect of the
menopause on age related trends then no effect of the menopause on
breast cancer trends among Japanese women might be expected.
![]()
Methods and results
Top
Methods and results
Comment
References

View larger version (24K):
[in a new window]
Age specific trends in mortality from coronary heart disease in
men and women and from breast cancer in women. Aggregated data for
England and Wales (top) and Japan (bottom)
![]()
Comment
Top
Methods and results
Comment
References
| |
Acknowledgments |
|---|
Contributors: All authors conceived the idea for the study. DAL undertook the analysis and wrote the first draft of the paper. All authors contributed to the final report. DAL will act as guarantor.
| |
Footnotes |
|---|
Funding: DAL is an MRC research training fellow and is funded by the Medical Research Council. Views expressed are those of the authors.
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. | Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet 1998; 351: 1425-1427[CrossRef][Web of Science][Medline]. |
| 2. | Tracy RE. Sex difference in coronary disease: two opposing views. J Chronic Dis 1966; 19: 1245-1251[CrossRef][Web of Science][Medline]. |
| 3. | Meilahn E. Sex steroid hormonal influences on coronary artery disease. In: Ness RB, Kuller LH, eds. Health and disease among women. Oxford: Oxford University Press, 1999:155-182. |
| 4. | Witteman JCM, Moerman CJ, Westendorp ICD. Myth of the menopause paradox. Lancet 1998; 352: 407. |
| 5. |
Lawlor DA, Ebrahim S, Davey Smith G.
Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality.
BMJ
2001;
323:
541-545 |
(Accepted 12 February 2002)